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This study represents an aggregation of knowledge on mastitis within the Australian dairy 
industry. Aspects of the epidemiology and economics of mastitis have been collated and 
areas of missing knowledge identified. A clinical treatment trial was conducted on 
subclinical mastitis to identify the role of therapy upon subclinical infection. The effect of 
individual variables on mastitis risk was studied and aggregated in order to facilitate the 
development of a computer simulation model of mastitis within Australian dairy herds. 
A literature review of mastitis within the Australian dairy industry was conducted. The 
economic impact of mastitis was examined and the pathway of economic loss to the dairy 
industry is discussed. The epidemiology of mastitis was studied with special emphasis on 
quantification of the effect of individual risk factors on the occurrence of disease. 
Performance parameters for the current diagnostic tests applied within the dairy industry 
are presented and their suitability for use in a commercial environment discussed. The 
impact of self-cure and the efficacy of therapeutic intervention in the disease are examined. 
The role of culling is presented. The chapter concludes with an estimation of the total 
economic losses experienced on a commercial dairy fa.on in Victoria in 1998 for three 
different mastitis levels. The economic benefit to be gained from a reduction in mastitis is 
also presented. 
A clinical treatment trial of subclinically infected cows (high somatic cell count) was 
conducted in order to determine if therapeutic intervention was an effective management 
tool. Cows with somatic cell counts in excess of 500,000 cells per ml and more than 14 
days calved were selected and randomly assigned to treatment and control groups. A 
pooled quarter milk sample was taken prior to treatment and repeated at around six weeks 
after treatment. Treated cows received a course of intramammary and pru:enteral antibiotics 
and control cows were untreated. Cows were followed for the rest of the lactation of 
treatment and into the subsequent lactation and somatic cell counts were recorded. The 
major pathogens identified were S aureus and S uberis. Treatment did not have a significant 
or commercially useful effect upon bacteriological cure rates, survival of cows to the next 
lactation or somatic cell count for the remainder of the lactation. Treatment of high 
somatic cell count cows during lactation is not recommended and is discussed. 
11 
A requirement exists for the development of a stochastic simulation model of mastitis 
within Australian dairy herds. The structure of such a model was developed and is 
presented. Underly1ng production and somatic cell count responses in Australian cattle 
were derived. Infection status variables were included and stochasticity was introduced 
through the use of control variates. State transition probabilities were collected from the 
literature. Deficiencies in knowledge were identified and methods for modelling these 
deficient areas discussed. The aggregated information is presented. It is expected that a 
working stochastic simulation model of mastitis within Australian dairy herds will be 
developed from information collected in this dissertation. 
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